Condition: Severe Emphysema · Sponsor: Shanghai Chest Hospital
To compare the efficacy and safety of subsegmental treatment and segmental treatment with InterVapor in patients with severe emphysema
This description comes directly from the study's public registry record.
Jiayuan Sun, MD., PhD. · 86-021-22200000 · jysun1976@163.com
Huan Hou, MD., PhD. · 2298544599@qq.com
Always discuss trial participation with your own doctor first.
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Recruiting |
| Emergency General Hospital | Beijing, China | Not Yet Recruiting |
| West China Hospital of Sichuan University | Chengdu, China | Not Yet Recruiting |
| Linyi People's Hospital | Linyi, China | Not Yet Recruiting |
| Jiangxi Provincial People's Hospital | Nanchang, China | Not Yet Recruiting |
| Shanghai Chest Hospital | Shanghai, China | Recruiting |
| Shanghai Sixth People's Hospital | Shanghai, China | Not Yet Recruiting |
| Hebei Provincial People's Hospital | Shijiazhuang, China | Not Yet Recruiting |
| Sir Run Run Shaw Hospital affiliated to Zhejiang University School of Medicine | Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06152107